aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Armetheon, Inc. is a clinical-stage biopharmaceutical company based in the San Francisco Bay Area. The company is dedicated to developing novel drugs for highly unmet medical needs. Armetheon focuses on advancing several programs currently in clinical development, aiming to address critical gaps in healthcare with innovative therapeutic solutions.
Armetheon has made significant strides in its clinical programs, demonstrating its commitment to addressing unmet medical needs. The company's efforts have garnered attention within the biopharmaceutical industry, positioning it as a promising player in the development of novel therapeutics.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Biopharmaceuticals
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Armetheon founded?
Armetheon was founded in 2011.
Where is Armetheon’s headquarters located?
Armetheon’s headquarters is located in Menlo Park, CA, US.
When was Armetheon’s last funding round?
Armetheon’s most recent funding round was for $24.3M (USD) in February 2015.
How many employees does Armetheon have?
Armetheon has 30 employees as of Feb 5, 2024.
How much has Armetheon raised to-date?
As of July 05, 2023, Armetheon has raised a total of $31.3M (USD) since Feb 5, 2015.
Add Comparison
Total Raised to Date
$31.3M
USD
Last Update Feb 5, 2015
Last Deal Details
$24.3M
USD
Feb 5, 2015
Series B
Total Employees Over Time
30
As of Feb 2024
Armetheon Address
Drive
# 303
Menlo Park,
California
94025
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts